CYP17 inhibitor/anti-androgen VN/124-1 inhibits growth of androgen independent prostate cancer cells through induction of the endoplasmic reticulum stress response

被引：0
|
作者：
Bruno, Robert [1 ]
Burger, Angelika [1 ]
Brodie, Angela [1 ]
Njar, Vincent [1 ]
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
来源：
CANCER RESEARCH | 2008年 / 68卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1585
引用
收藏
页数：2
相关论文
共 31 条
  • [21] Sphingosine 1-phosphate-induced autophagy is mediated through activating endoplasmic reticulum stress response in human prostate cancer PC-3 cells
    Shih, Chih-Jen
    Huang, Yuan-Li
    Chang, Chi-Lun
    Huang, Wei-Pang
    Lee, Hsinyu
    FASEB JOURNAL, 2010, 24
  • [22] Anti-Proliferative Effect and Induction of Apoptosis in Androgen-Independent Human Prostate Cancer Cells by 1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one
    Citalingam, Kamini
    Abas, Faridah
    Lajis, Nordin H.
    Othman, Iekhsan
    Naidu, Rakesh
    MOLECULES, 2015, 20 (02) : 3406 - 3430
  • [23] Cytochrome P450 17A1 inhibitor abiraterone attenuates cellular growth of prostate cancer cells independently from androgen receptor signaling by modulation of oncogenic and apoptotic pathways
    Grossebrummel, Hannah
    Peter, Tilmann
    Mandelkow, Robert
    Weiss, Martin
    Muzzio, Damian
    Zimmermann, Uwe
    Walther, Reinhard
    Jensen, Federico
    Knabbe, Cornelius
    Zygmunt, Marek
    Burchardt, Martin
    Stope, Matthias B.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (02) : 793 - 800
  • [24] Bergamottin a CYP3A inhibitor found in grapefruit juice inhibits prostate cancer cell growth by downregulating androgen receptor signaling and promoting G0/G1 cell cycle block and apoptosis
    Vetrichelvan, Opalina
    Gorjala, Priyatham
    Goodman, Oscar
    Mitra, Ranjana
    PLOS ONE, 2021, 16 (09):
  • [25] Overexpression of estrogen receptor-related receptor β\ (ERRβ) suppresses the cell proliferation and tumor growth of androgen-dependent and - independent prostate cancer cells via induction of p21Cip1/Waf1
    Yu, Shan
    Wang, Xianghong
    Chan, Franky L.
    CANCER RESEARCH, 2006, 66 (08)
  • [26] Baseline circulating tumor cell (CTC) count as a prognostic marker of PSA response and progression in metastatic castrate sensitive prostate cancer (mCSPC): Results from SWOG S1216, a phase III randomized trial of androgen deprivation plus orteronel (cyp17 inhibitor) or bicalutamide.
    Goldkorn, Amir
    Tangen, Catherine
    Plets, Melissa
    Morrison, Gareth
    Cunha, Alexander
    Xu, Tong
    Pinski, Jacek K.
    Ingles, Sue A.
    Triche, Timothy
    MacVicar, Gary R.
    Vaena, Daniel A.
    Crispino, Anthony W.
    McConkey, David James
    Lara, Primo
    Hussain, Maha H. A.
    Quinn, David, I
    Vogelzang, Nicholas J.
    Thompson, Ian Murchie
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] 1,1-bis(3′-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor γ-independent pathways
    Chintharlapalli, Sudhakar
    Papineni, Sabitha
    Safe, Stephen
    MOLECULAR PHARMACOLOGY, 2007, 71 (02) : 558 - 569
  • [28] Effects of the selective CYP17-lyase and androgen receptor (AR) inhibitor, seviteronel, and the cyclin-dependent kinase (CDK) 4/6 inhibitor, G1T38, on tumor growth in an AR-V7+castration-resistant prostate cancer (CRPC) xenograft model
    Wardell, Suzanne E.
    Yllanes, Alexander P.
    Norris, John D.
    Stice, James P.
    White, Hannah
    Fleming, Ronald A.
    Strum, Jay C.
    Moore, William R.
    McDonnell, Donald P.
    CANCER RESEARCH, 2017, 77
  • [29] Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C
    Li, Jing
    Xiang, SongTao
    Zhang, QiouHong
    Wu, JingJing
    Tang, Qing
    Zhou, JianFu
    Yang, Lijun
    Chen, ZhiQiang
    Hann, Swei Sunny
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
  • [30] Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C
    Jing Li
    SongTao Xiang
    QiouHong Zhang
    JingJing Wu
    Qing Tang
    JianFu Zhou
    LiJun Yang
    ZhiQiang Chen
    Swei Sunny Hann
    Journal of Experimental & Clinical Cancer Research, 34
1234